Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josep Julve

Showing results (71-80 of 124) with videos related to

Pageof 13
Sort By:
Cardiovascular Diabetology|November 26, 2022
The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitusCarlos Puig-Jové, Josep Julve, Esmeralda Castelblanco, et al.
Diabetes Research and Clinical Practice|November 17, 2021
Outstanding improvement of the advanced lipoprotein profile in subjects with new-onset type 1 diabetes mellitus after achieving optimal glycemic controlEsmeralda Castelblanco, Marta Hernández, Emilio Ortega, et al.
Cardiovascular Diabetology|October 11, 2022
Association of α-klotho with subclinical carotid atherosclerosis in subjects with type 1 diabetes mellitusEsmeralda Castelblanco, Marta Hernández, Nuria Alonso, et al.
Nutrients|September 27, 2025
Fecal Short-Chain Fatty Acids to Predict Prediabetes and Type 2 Diabetes Risk: An Exploratory Cross-Sectional StudyRocío Puig, Marina Idalia Rojo-López, Josep Julve, et al.
Frontiers in Endocrinology|July 4, 2024
Therapeutic implications for sphingolipid metabolism in metabolic dysfunction-associated steatohepatitisBruno Ramos-Molina, Joana Rossell, Alejandra Pérez-Montes de Oca, et al.
British Journal of Pharmacology|March 25, 2023
Targeting mitochondrial stress with Szeto-Schiller 31 prevents experimental abdominal aortic aneurysm: Crosstalk with endoplasmic reticulum stressMiquel Navas-Madroñal, Rafael Almendra-Pegueros, Lidia Puertas-Umbert, et al.
Journal of Lipid Research|January 12, 2013
Structural and functional analysis of APOA5 mutations identified in patients with severe hypertriglyceridemiaElena Mendoza-Barberá, Josep Julve, Stefan K Nilsson, et al.
Experimental and Molecular Pathology|October 9, 2007
Deficiency in monocyte chemoattractant protein-1 modifies lipid and glucose metabolismAnna Rull, Joan Carles Escolà-Gil, Josep Julve, et al.
Journal of Clinical Medicine|March 10, 2022
TMAO and Gut Microbial-Derived Metabolites TML and γBB Are Not Associated with Thrombotic Risk in Patients with Venous ThromboembolismMarina Canyelles, Melania Plaza, Noemí Rotllan, et al.
Diagnostics (Basel, Switzerland)|November 26, 2022
Divergent Effects of Glycemic Control and Bariatric Surgery on Circulating Concentrations of TMAO in Newly Diagnosed T2D Patients and Morbidly ObeseMarina Canyelles, Antonio Pérez, Alexandra Junza, et al.
Pageof 13

Showing results (71-80 of 124) with videos related to

Sort By:
Pageof 13
Cardiovascular Diabetology|November 26, 2022
The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitusCarlos Puig-Jové, Josep Julve, Esmeralda Castelblanco, et al.
Diabetes Research and Clinical Practice|November 17, 2021
Outstanding improvement of the advanced lipoprotein profile in subjects with new-onset type 1 diabetes mellitus after achieving optimal glycemic controlEsmeralda Castelblanco, Marta Hernández, Emilio Ortega, et al.
Cardiovascular Diabetology|October 11, 2022
Association of α-klotho with subclinical carotid atherosclerosis in subjects with type 1 diabetes mellitusEsmeralda Castelblanco, Marta Hernández, Nuria Alonso, et al.
Nutrients|September 27, 2025
Fecal Short-Chain Fatty Acids to Predict Prediabetes and Type 2 Diabetes Risk: An Exploratory Cross-Sectional StudyRocío Puig, Marina Idalia Rojo-López, Josep Julve, et al.
Frontiers in Endocrinology|July 4, 2024
Therapeutic implications for sphingolipid metabolism in metabolic dysfunction-associated steatohepatitisBruno Ramos-Molina, Joana Rossell, Alejandra Pérez-Montes de Oca, et al.
British Journal of Pharmacology|March 25, 2023
Targeting mitochondrial stress with Szeto-Schiller 31 prevents experimental abdominal aortic aneurysm: Crosstalk with endoplasmic reticulum stressMiquel Navas-Madroñal, Rafael Almendra-Pegueros, Lidia Puertas-Umbert, et al.
Journal of Lipid Research|January 12, 2013
Structural and functional analysis of APOA5 mutations identified in patients with severe hypertriglyceridemiaElena Mendoza-Barberá, Josep Julve, Stefan K Nilsson, et al.
Experimental and Molecular Pathology|October 9, 2007
Deficiency in monocyte chemoattractant protein-1 modifies lipid and glucose metabolismAnna Rull, Joan Carles Escolà-Gil, Josep Julve, et al.
Journal of Clinical Medicine|March 10, 2022
TMAO and Gut Microbial-Derived Metabolites TML and γBB Are Not Associated with Thrombotic Risk in Patients with Venous ThromboembolismMarina Canyelles, Melania Plaza, Noemí Rotllan, et al.
Diagnostics (Basel, Switzerland)|November 26, 2022
Divergent Effects of Glycemic Control and Bariatric Surgery on Circulating Concentrations of TMAO in Newly Diagnosed T2D Patients and Morbidly ObeseMarina Canyelles, Antonio Pérez, Alexandra Junza, et al.
Pageof 13